PharmaBlock buys plant in China from Porton Pharma

27th September 2018 Uncategorised 0

China’s PharmaBlock Sciences says it has acquired a GMP-compliant manufacturing facility from Porton Pharma Solutions in Shangyu, China, where it will make intermediates.

More: PharmaBlock buys plant in China from Porton Pharma
Source: fierce